ATE318908T1 - Synthetische gene für gagpol und deren verwendungen - Google Patents

Synthetische gene für gagpol und deren verwendungen

Info

Publication number
ATE318908T1
ATE318908T1 AT00110623T AT00110623T ATE318908T1 AT E318908 T1 ATE318908 T1 AT E318908T1 AT 00110623 T AT00110623 T AT 00110623T AT 00110623 T AT00110623 T AT 00110623T AT E318908 T1 ATE318908 T1 AT E318908T1
Authority
AT
Austria
Prior art keywords
gagpol
synthetic genes
generation
synthetic gag
gagpol genes
Prior art date
Application number
AT00110623T
Other languages
English (en)
Inventor
Ralf Wagner
Markus Graf
Ludwig Deml
Kurt Bieler
Original Assignee
Geneart Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8168767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE318908(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Geneart Gmbh filed Critical Geneart Gmbh
Application granted granted Critical
Publication of ATE318908T1 publication Critical patent/ATE318908T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00110623T 2000-05-18 2000-05-18 Synthetische gene für gagpol und deren verwendungen ATE318908T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00110623A EP1156112B1 (de) 2000-05-18 2000-05-18 Synthetische Gene für gagpol und deren Verwendungen

Publications (1)

Publication Number Publication Date
ATE318908T1 true ATE318908T1 (de) 2006-03-15

Family

ID=8168767

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00110623T ATE318908T1 (de) 2000-05-18 2000-05-18 Synthetische gene für gagpol und deren verwendungen
AT01960229T ATE333503T1 (de) 2000-05-18 2001-05-18 Synthetische gene für gagpol und deren verwendungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT01960229T ATE333503T1 (de) 2000-05-18 2001-05-18 Synthetische gene für gagpol und deren verwendungen

Country Status (10)

Country Link
US (3) US7378515B2 (de)
EP (2) EP1156112B1 (de)
CN (1) CN1429270A (de)
AT (2) ATE318908T1 (de)
AU (1) AU2001281781A1 (de)
BR (1) BR0110706A (de)
CA (1) CA2408433A1 (de)
DE (2) DE60026199T2 (de)
HK (1) HK1042319B (de)
WO (1) WO2001088141A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004508064A (ja) * 2000-09-15 2004-03-18 メルク　エンド　カムパニー　インコーポレーテッド コドン最適化ｈｉｖ１−ｇａｇ、ｐｏｌ、ｎｅｆおよび修飾体を発現する増強された第１世代アデノウイルスワクチン
EP1201750A1 (de) * 2000-10-26 2002-05-02 Genopoietic Synthetische Viren und ihre Verwendungen
JP4601956B2 (ja) * 2001-09-20 2010-12-22 グラクソ グループ リミテッド Ｈｉｖ−ｇａｇのコドン最適化ｄｎａワクチン
DE10260805A1 (de) 2002-12-23 2004-07-22 Geneart Gmbh Verfahren und Vorrichtung zum Optimieren einer Nucleotidsequenz zur Expression eines Proteins
WO2004058166A2 (en) 2002-12-23 2004-07-15 Vical Incorporated Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
US20050220816A1 (en) * 2004-03-31 2005-10-06 Advanced Bioscience Laboratories, Inc. Mutant viral nucleic acids and vaccine containing same
DE102004037611B4 (de) * 2004-08-03 2013-10-02 Geneart Ag Induzierbare Genexpression
CA2575490A1 (en) * 2004-08-03 2006-02-16 Frank Notka Method for modulating gene expression by altering the cpg content
ES2281252B1 (es) * 2005-07-27 2009-02-16 Consejo Superior De Investigaciones Cientificas Vectores recombinantes basados en el virus modificado de ankara (mva) como vacunas preventivas y terapeuticas contra el sida.
US8323891B2 (en) * 2008-08-01 2012-12-04 Claflin University miRNA triplex formations for the downregulation of viral replication
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
EP2620446A1 (de) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogene zur HIV-Impfung
JP6224077B2 (ja) 2012-04-17 2017-11-01 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 改変された核酸を用いてポリペプチドを発現させるための方法
CN113924114A (zh) 2019-05-22 2022-01-11 吉利德科学公司 Tlr7调节化合物和hiv疫苗的组合
BR112021025806A2 (pt) 2019-06-28 2022-02-08 Hoffmann La Roche Métodos para produzir um anticorpo da subclasse igg1 humana cultivando uma célula cho e uso da remoção de sítios de splice de doador não pareados em uma parte de uma sequência de ácido nucleico de humano ou hamster
AU2020384323A1 (en) 2019-11-14 2022-06-02 Aelix Therapeutics, S.L. Dosage regimens for vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE9900343A (et) * 1997-02-07 2000-02-15 Merck & Co., Inc. Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
AU6139699A (en) * 1998-09-11 2000-04-03 Children's Medical Center Corporation Packaging cell lines for hiv-derived retroviral vector particles
EP1141314A2 (de) * 1998-12-31 2001-10-10 Chiron Corporation Für antigene polypeptide des hiv type c kodierende polynukleotide, entsprechende polypeptide und verwendungen davon

Also Published As

Publication number Publication date
WO2001088141A3 (en) 2002-04-18
HK1042319A1 (en) 2002-08-09
HK1042319B (en) 2006-10-20
DE60026199T2 (de) 2006-11-23
US7378515B2 (en) 2008-05-27
US20130122585A1 (en) 2013-05-16
AU2001281781A1 (en) 2001-11-26
EP1156112B1 (de) 2006-03-01
US20070293448A1 (en) 2007-12-20
EP1282712B1 (de) 2006-07-19
DE60026199D1 (de) 2006-04-27
US20040152069A1 (en) 2004-08-05
DE60121572D1 (de) 2006-08-31
EP1156112A1 (de) 2001-11-21
CA2408433A1 (en) 2001-11-22
WO2001088141A2 (en) 2001-11-22
CN1429270A (zh) 2003-07-09
BR0110706A (pt) 2003-01-28
US8287881B2 (en) 2012-10-16
ATE333503T1 (de) 2006-08-15
HK1053853A1 (en) 2003-11-07
DE60121572T2 (de) 2007-06-28
EP1282712A2 (de) 2003-02-12

Similar Documents

Publication Publication Date Title
DE60026199D1 (de) Synthetische Gene für gagpol und deren Verwendungen
ATE361366T1 (de) Aus bacillus stammende transglutaminase
MXPA03000634A (es) Metodos para el reemplazo, el desplazamiento y acumulacion de adn en genomas eucarioticos.
MEP44408A (en) Anti-il-12 antibodies, compositions, methods and uses
IL143326A0 (en) Method of cloning porcine animals
HRP20030088A2 (en) Anti-dual integrin antibodies, compositions, methods and uses
ATE257175T1 (de) Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
WO2003000038A3 (en) Compositions and methods for modulating plant development
ATE463560T1 (de) Fad4, fad5, fad5-2, and fad6, mitglieder der fettsäuredesaturasefamilie und ihre verwendungen
ATE426661T1 (de) Somatische pluripotente zellen
BR0214366A (pt) construção de ácido nucleico recombinante, célula e, métodos para produzir ácido láctico, e para reduzir a atividade de piruvato descarboxilase em uma célula
ATE256196T1 (de) Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten
DE69914954D1 (de) Aus substrathaltigen gasgemischen aethanol erzeugende clostridium stamme
DK1321477T3 (da) Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
DE59807012D1 (de) Flip-gen und flip-protein
ITMI20040363A1 (it) Cassetta per l'espressione di acidi nucleici negli stomi
DE60042816D1 (de) T-helferzellen-epitope
TR200001046T2 (tr) Homolog rekombinasyonda pozitif-negatif seçimi.
ATE171212T1 (de) Corticotropin freisetzende rezeptoren des faktor 2
DE60233756D1 (de) Vektorvermittelte organellentransfektion
ATE408009T1 (de) Identifizierung und charakterisierung einer anthocyaninmutante (ant1) in tomate
PL367306A1 (pl) Szczepionki na bazie autologicznych komórek T i sposoby ich otrzymywania
DE69940022D1 (de) Promotoren für wachstums-differenzierungsfaktoren und deren verwendung
ATE324446T1 (de) Mutante formen von etxb und ctxb und ihre verwendung als träger
ZA200404424B (en) Genes encoding for genetic stability, gene expression and folding proteins.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1156112

Country of ref document: EP

EEIH Change in the person of patent owner